Event Type
Disclosure
Mandatory
Variant
8-K
Entry into a Material Definitive Agreement. Term Sheet On January 20, 2026, Lisata Therapeutics, Inc., a Delaware corporation (the “ Company ” or “ Lisata ”), e
. Other Events. Press Release On January 21, 2026, the Company issued a press release regarding the execution of the Term Sheet. A copy of such press release ha
Financial Statements and Exhibits. (d) Exhibits Exhibit No Description 2.1 * Binding Term Sheet, dated January 20, 2026, by and among the Company and Kuva Labs,